| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(05)83505-X |
| P698 | PubMed publication ID | 8419599 |
| P2093 | author name string | Bejar R | |
| Edwards D | |||
| Hallman M | |||
| Merritt TA | |||
| Pohjavuori M | |||
| Vaucher YE | |||
| Heldt GP | |||
| Harker L | |||
| Gist K | |||
| P2860 | cites work | Surfactant-replacement therapy | Q70111600 |
| Follow up of premature babies treated with artificial surfactant (ALEC). | Q35066317 | ||
| Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm | Q40671726 | ||
| Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. | Q41180671 | ||
| A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation | Q42072584 | ||
| Prophylactic treatment of very premature infants with human surfactant | Q43601069 | ||
| Cerebral blood flow velocity after surfactant instillation in preterm infants. | Q45936459 | ||
| Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity | Q46372703 | ||
| Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant | Q47438728 | ||
| Growth and development two years after artificial surfactant replacement at birth. | Q52261209 | ||
| Surfactant replacement therapy in respiratory distress syndrome. Meta-analysis of clinical trials of single-dose surfactant extracts | Q67897256 | ||
| Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1 | Q68194824 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| placebo-controlled trial | Q108853737 | ||
| birth mass | Q4128476 | ||
| P304 | page(s) | 126-132 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant | |
| P478 | volume | 122 |
| Q74556252 | A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome |
| Q33948316 | Antecedents of cerebral palsy in very low-birth weight infants |
| Q40726641 | Clinical trials of natural surfactant extract in respiratory distress syndrome. |
| Q40684981 | Current surfactant use in premature infants |
| Q35288392 | Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant |
| Q24815457 | Palatal development of preterm and low birthweight infants compared to term infants - What do we know? Part 1: The palate of the term newborn |
| Q24201075 | Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants |
| Q33608041 | Pulmonary surfactant therapy. |
| Q71871084 | Surfactant replacement therapy |
| Q74191217 | Surfactant replacement therapy--economic impact |
Search more.